Inovio gets second grant to fund bioterrorism synthetic vaccines

Via Scoop.itVirology News

Inovio Pharmaceuticals (AMEX:INO) received a second grant by the U.S. Defence Department to fund bioterrorism synthetic vaccines program, the company said Monday.

The grant allows Inovio to advance development of a low-cost, non-invasive surface electroporation delivery device and test its utility with its novel synthetic DNA-based vaccines against viruses with a bioterrorism potential, including hanta, puumala,
arenavirus and pandemic influenza.

 

Good may come of the bioterror hype yet!

Via www.proactiveinvestors.com

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: